Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha. - Wikidata - wikimedia - TriplyDB

Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha.

Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha.

http://www.wikidata.org/entity/Q38518574

about

Cancer as a metabolic disease Hypoxia-inducible factors as molecular targets for liver diseases Potential mechanisms of hepatitis B virus induced liver injury Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma.HIF-1alpha: a valid therapeutic target for tumor therapy Hepatitis B virus protein X-induced expression of the CXC chemokine IP-10 is mediated through activation of NF-kappaB and increases migration of leukocytes.Hypoxia inducible factor-1 alpha activation of the JCV promoter: role in the pathogenesis of progressive multifocal leukoencephalopathy Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.Overexpression of cyclooxygenase-2 in noncancerous liver tissue increases the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis.Angiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration.Carbon monoxide promotes VEGF expression by increasing HIF-1alpha protein level via two distinct mechanisms, translational activation and stabilization of HIF-1alpha protein.Targeted genes and interacting proteins of hypoxia inducible factor-1.Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor.Differential functions of C- and N-terminal hepatitis B x protein in liver cells treated with doxorubicin in normoxic or hypoxic condition.Tumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic target in non-small cell lung cancer Hepatitis B virus X protein and the estrogen receptor variant lacking exon 5 inhibit estrogen receptor signaling in hepatoma cells Hypoxia-Inducible Factor (HIF) as a Pharmacological Target for Prevention and Treatment of Infectious Diseases The X protein of hepatitis B virus inhibits apoptosis in hepatoma cells through enhancing the methionine adenosyltransferase 2A gene expression and reducing S-adenosylmethionine production.Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma.Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib.Hepatitis B virus promotes angiopoietin-2 expression in liver tissue: role of HBV x protein Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do!Modulation of apoptotic signaling by the hepatitis B virus X protein.Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein.Chronic hepatitis B in hepatocarcinogenesis A network-based maximum link approach towards MS identifies potentially important roles for undetected ARRB1/2 and ACTB in liver cancer progression.Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma.BC-box protein domain-related mechanism for VHL protein degradation.Interdependence of hypoxic and innate immune responses Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.Hypoxic and highly angiogenic non-tumor tissues surrounding hepatocellular carcinoma: the 'niche' of endothelial progenitor cells.Hepatocellular carcinoma: the point of view of the hepatitis B virus.Wild type HBx and truncated HBx: Pleiotropic regulators driving sequential genetic and epigenetic steps of hepatocarcinogenesis and progression of HBV-associated neoplasms.Hypoxia inducible factors in hepatocellular carcinoma Dissecting the pleiotropic actions of HBx mutants against hypoxia in hepatocellular carcinoma.A compendium of proteins that interact with HIF-1α.Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter.NF-kappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx.Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells.

P2860

Q21245061-DABB254C-5AA9-45DB-9A9B-C17399BEB731 Q26752304-BC564C5F-912A-4B78-88F7-4B1E97D49E20 Q27014079-A8D4AF5B-F80F-444A-A687-9877410BDC21 Q30397068-33BD8E0F-A4C1-4549-829B-47DC3FEF06C1 Q33289829-BB703305-7326-4760-B438-7015687BDDA7 Q33746822-B124B15A-4D95-4E3B-9979-AD2453482962 Q33782559-B88E66CD-ABDC-491F-8060-035317191A33 Q33796549-C3A02E35-D176-4D87-B25B-94D5ED41CD15 Q33855801-854EE0A7-930A-4FED-9799-76F345FD43CA Q34053320-8AA00257-16F1-4D0F-B385-C37A76B942C2 Q34130424-4EC37101-C4FC-4C81-AC69-5F7C1EBE5D11 Q34186417-23F5835F-09D3-4339-A7A0-1B30787A95D9 Q34286796-48EEF467-5855-4A78-8338-B0C7A6201BB0 Q34324015-F65A3F31-8A09-4AE6-8BD5-84232AC3DF11 Q34499932-1A21C204-3A34-4220-9B33-528A80774BD2 Q34657698-6627D8F0-16F8-4690-AA09-4C70303563CA Q34666783-4BD74FFC-6E2A-49DB-9DC5-125934EC818F Q34726144-66C455E6-7712-4504-BB53-D75322E6907B Q34948099-096386FF-C384-442A-834E-624EF711568E Q35010488-50F50D43-1790-4DF0-AEF0-413A3DEF8214 Q35184195-31D0568A-1DB0-4B87-93F8-50BB28653C8B Q35222133-CB3983C8-72DF-4DB0-BFFA-C66218C4F6FE Q36084438-9A5B08C5-299D-432B-8D8F-9FAE70D58BA4 Q36432730-58F51672-ED6C-4FF8-8762-E3F454151965 Q36463282-7B4CE736-4FEC-4AAF-A0AB-0A8342339C80 Q36557635-4B393403-F0C1-4E92-9CFB-46A0B8576DC0 Q37201047-B992494D-C896-46F7-A18E-5DD68DC998FC Q37281965-B3F4040E-E724-4F57-94F9-839BB1BFB204 Q37318235-44F01616-13FA-4FBE-8D9C-0C7B9E3E5B3D Q37586121-A1571A0D-034B-4C62-AB34-BCCCABA778C8 Q37810431-DD8570DF-E370-4649-B485-B670E7309A13 Q37820212-E4D9D0B7-825D-4948-A795-4D71029B7E8B Q37888329-99C87041-B1CB-4DCD-B108-13B92389EB7E Q38643087-FD48FB4C-C568-4C17-B656-5092906A70D1 Q38685135-8592988B-E8BB-4D6A-9067-860AFBB68ADB Q38961911-D329F6ED-CBD4-4146-941A-00A4D11CFFAE Q39197245-4BBF84B9-417E-4640-99A2-5F655737F9C6 Q39646942-01E6C3BB-228E-4EC4-984A-3A68969A1540 Q39725462-780AEA04-5349-49BF-A88B-FBFFFE27754C Q40118264-A05D6ED0-4F62-45A1-856F-4C9BBFB8D801

P2860

Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha.

http://www.wikidata.org/entity/Q38518574

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Hepatitis B virus X protein in ...... poxia-inducible factor-1alpha.

@en

type

label

Hepatitis B virus X protein in ...... poxia-inducible factor-1alpha.

@en

prefLabel

Hepatitis B virus X protein in ...... poxia-inducible factor-1alpha.

@en

P1433

Q38518574-09D9D1AE-6A0C-4BA9-BEB4-D8782BB6BE43

P1476

Q38518574-7526BB1F-9F65-4259-B1CA-756D182DD316

P2093

Q38518574-2023BD11-AA0A-4483-BBF2-760A7CFDB176

Q38518574-22066CF6-117A-4358-B09B-BDC41E12967B

Q38518574-23A5BDAF-79B7-47CC-8194-415CA97C1F52

Q38518574-41FD3FA8-BBAD-4984-A507-62CCC8AFD5BF

Q38518574-8000263F-8762-4E86-A5B2-DE0F6685E1D3

Q38518574-A924C0FA-B6C8-4EE8-B942-425B4B606165

Q38518574-D72D1261-428A-43A9-968B-3B1F077502DF

Q38518574-E7644DB1-0B3B-4857-9F7E-E41595E798DF

P304

Q38518574-8A1DACDA-642B-4D2A-8639-7D519CCEA25B

P31

Q38518574-E82FC112-29A7-4C86-A645-180F40FDAD92

P356

Q38518574-13956934-9D35-4294-A931-F6ACC7A02E84

P407

Q38518574-3699DA8E-3058-45BD-9EDF-50CC1872D69C

P433

Q38518574-A9A61E9F-6E75-4E5E-8ED0-09B8101209B2

P478

Q38518574-FB587E6E-E8B4-48FD-9E4A-D2EAFEBB9F38

P577

Q38518574-912B8607-E69D-40FF-BF0B-9051BD752EA0

P698

Q38518574-FAB0465D-4D64-4799-B850-B741D74AA1F4

P921

Q38518574-EE366C8F-7071-4A63-88E0-2B75A9DE3F9F

P356

P1433

P1476

Hepatitis B virus X protein in ...... poxia-inducible factor-1alpha.

@en

P2093

Chul Woo Kim

http://www.w3.org/2001/XMLSchema#string

Chul-Ho Jeong

http://www.w3.org/2001/XMLSchema#string

Dae-Yeul Yu

http://www.w3.org/2001/XMLSchema#string

Eun-Joung Moon

http://www.w3.org/2001/XMLSchema#string

Joo-Won Jeong

http://www.w3.org/2001/XMLSchema#string

Kwang Rok Kim

http://www.w3.org/2001/XMLSchema#string

Kyu-Won Kim

http://www.w3.org/2001/XMLSchema#string

Seishi Murakami

http://www.w3.org/2001/XMLSchema#string

P304

382-384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.03-0153FJE

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14688211

http://www.w3.org/2001/XMLSchema#string

P921